Clinical Trials

Request An Appointment

Phone: (310) 794-7700

UCLA Urology Clinical Trials for Kidney Cancer

A clinical trial is a study conducted with actual patients, usually to evaluate a new treatment. Each study is designed to answer scientific questions and to find new and better ways to help patients.

Ongoing Clinical Trials for Kidney Cancer:

• Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Data and Biospecimen Repository
• GU Cancer Repository for Genitourinary Cancers

• Stool Microbiome and Immunotherapy Response and Toxicity

• The Enhanced Renal Mass Biopsy: Impact on Clinical Decision-Making for the Localized Renal Mass

• A Phase 3 Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab Combination vs Placebo in Participants with Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse (BMS Checkmate)

• 99mTc-sestamibi Imaging for the Characterization of Renal Masses: Impact on Clinical Decision Making

• A Study of NKT2152, a HIF2α Inhibitor, in Patients with Advanced Clear Cell Renal Cell Carcinoma

• Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer

• Genomic and transcriptomic library of Renal Neoplasms

For more information

For information on inclusion and exclusion criteria please call our Clinical Trials Office: 310-206-5930

• Frequently Asked Questions
• UCLA Office of Clinical Trials
• UCLA Jonsson Comprehensive Cancer Center